TOPIC

PLASMA News & Analysis

CSL flags softer growth after strong FY profit
Stocks
CSL flags softer growth after strong FY profit
And Morningstar analyst Nicolette Quinn has tempered her forecasts for sales of immunoglobulins.
Prashant Mehra | 19 August 2020
Local biotech, hospital hardware names riding high
Stocks
Local biotech, hospital hardware names riding high
Fisher & Paykel’s share price has soared as COVID-19 cases rise in Australia, US and Europe, while CSL’s latest acquisition marks...
Glenn Freeman | 01 July 2020
CSL remains favourite, but biotech field broadening
Stocks
CSL remains favourite, but biotech field broadening
The biotech giant has jumped 22pc a year for the past decade but new players are emerging.
Nicki Bourlioufas | 07 April 2019